SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-15-000231
Filing Date
2015-08-07
Accepted
2015-08-07 16:57:54
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20150630x10q.htm 10-Q 958668
2 EX-31.1 cort-20150630xex311.htm EX-31.1 17860
3 EX-31.2 cort-20150630xex312.htm EX-31.2 18274
4 EX-32.1 cort-20150630xex321.htm EX-32.1 9393
5 EX-32.2 cort-20150630xex322.htm EX-32.2 9684
  Complete submission text file 0001562762-15-000231.txt   2692931

Data Files

Seq Description Document Type Size
6 EX-101.INS cort-20150630.xml EX-101.INS 404981
7 EX-101.SCH cort-20150630.xsd EX-101.SCH 19184
8 EX-101.CAL cort-20150630_cal.xml EX-101.CAL 35652
9 EX-101.DEF cort-20150630_def.xml EX-101.DEF 37601
10 EX-101.LAB cort-20150630_lab.xml EX-101.LAB 150760
11 EX-101.PRE cort-20150630_pre.xml EX-101.PRE 120540
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 151038252
SIC: 2834 Pharmaceutical Preparations